These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 6237606

  • 1. In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.
    Guenthner SH, Wenzel RP.
    Antimicrob Agents Chemother; 1984 Aug; 26(2):268-9. PubMed ID: 6237606
    [Abstract] [Full Text] [Related]

  • 2. The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
    Moorhouse EC, Mulvihill TE, Jones L, Mooney D, Falkiner FR, Keane CT.
    J Antimicrob Chemother; 1985 Mar; 15(3):291-5. PubMed ID: 3158632
    [Abstract] [Full Text] [Related]

  • 3. Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
    Graninger W, Leitha T, Breyer S, Francesconi M, Lenz K, Georgopoulos A.
    Drugs Exp Clin Res; 1985 Mar; 11(1):23-7. PubMed ID: 3869801
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of penicillin G, flucloxacillin, cefazolin, fusidic acid, vancomycin, rifampicin and fosfomycin in muscular infections in mice due to Staphylococcus aureus.
    Haag R.
    Infection; 1986 Mar; 14(1):38-43. PubMed ID: 3957435
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Graninger W, Leitha T, Havel M, Georgopoulos A.
    Infection; 1984 Mar; 12(4):293-5. PubMed ID: 6092279
    [Abstract] [Full Text] [Related]

  • 6. Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureus.
    Vaudaux P, Huggler E, Bernard L, Ferry T, Renzoni A, Lew DP.
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3861-70. PubMed ID: 20547791
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of teichomycin A 2 in comparison with penicillin and vancomycin against gram-positive cocci.
    Bauernfeind A, Petermüller C.
    Eur J Clin Microbiol; 1982 Oct; 1(5):278-81. PubMed ID: 6223812
    [Abstract] [Full Text] [Related]

  • 8. In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus.
    Foldes M, Munro R, Sorrell TC, Shanker S, Toohey M.
    J Antimicrob Chemother; 1983 Jan; 11(1):21-6. PubMed ID: 6826485
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Pistella E, Falcone M, Baiocchi P, Pompeo ME, Pierciaccante A, Penni A, Venditti M.
    Infez Med; 2005 Jun; 13(2):97-102. PubMed ID: 16220029
    [Abstract] [Full Text] [Related]

  • 10. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Ishag AJ, Durgham SM, Shibl AM.
    Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of fosfomycin, alone and in combination, against methicillin-resistant Staphylococcus aureus.
    Alvarez S, Jones M, Berk SL.
    Antimicrob Agents Chemother; 1985 Nov; 28(5):689-90. PubMed ID: 3853963
    [Abstract] [Full Text] [Related]

  • 12. Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance.
    Del Bene VE, John JF, Twitty JA, Lewis JW.
    J Infect Dis; 1986 Aug; 154(2):349-52. PubMed ID: 2941491
    [No Abstract] [Full Text] [Related]

  • 13. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.
    Simon VC, Simon M.
    Scand J Infect Dis Suppl; 1990 Aug; 72():14-9. PubMed ID: 2151061
    [Abstract] [Full Text] [Related]

  • 14. In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
    Drugeon HB, Caillon J, Juvin ME.
    J Antimicrob Chemother; 1994 Dec; 34(6):899-907. PubMed ID: 7730233
    [Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo study of fosfomycin in methicillin-resistant Staphylococcus aureus septicaemia.
    Lau WY, Teoh-Chan CH, Fan ST, Lau KF.
    J Hyg (Lond); 1986 Jun; 96(3):419-23. PubMed ID: 3637200
    [Abstract] [Full Text] [Related]

  • 16. Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus.
    Maple PA, Hamilton-Miller JM, Brumfitt W.
    J Antimicrob Chemother; 1989 Apr; 23(4):517-25. PubMed ID: 2526111
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs.
    Vedel G, Leruez M, Lémann F, Hraoui E, Ratovohery D.
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):820-2. PubMed ID: 2150815
    [Abstract] [Full Text] [Related]

  • 18. Effect of vancomycin and teicoplanin alone or in combination with fusidic acid or amikacin against methicillin-resistant staphylococci.
    Roussel-Delvallez M, Wallet F, Barbiery P, Courcol RJ.
    J Chemother; 1997 Feb; 9(1):5-8. PubMed ID: 9106011
    [Abstract] [Full Text] [Related]

  • 19. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
    Shibl AM, Ishag AH, Durgham SM.
    APMIS Suppl; 1988 Feb; 3():68-70. PubMed ID: 2972301
    [Abstract] [Full Text] [Related]

  • 20. Gentamicin- and methicillin-resistant, clinical isolates of Staphylococcus aureus: comparative in vitro and in vivo efficacy of alternative antimicrobial drugs.
    Traub WH, Spohr M, Bauer D.
    Chemotherapy; 1984 Feb; 30(2):102-12. PubMed ID: 6559664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.